GGAL shorts build as earnings loom

GGAL heads into its May 22 earnings date with short sellers pressing harder and the stock down 7.5% on the week — a divergence from the broader Latin American banking complex.

Short interest is the clearest story this week. Shares short have climbed 11% over the past month, with the pace accelerating: the week ending April 28 saw a 6.8% jump to roughly 7.16 million shares. The ORTEX short score has drifted steadily higher, reaching 67.7 — its highest reading of the past two weeks — as that incremental pressure accumulates ahead of the Q1 print. The borrow market remains accessible despite the build, with cost to borrow running at just over 1% annualised. Availability has tightened somewhat — borrow utilisation is now at 79%, up from a range closer to 74-75% the prior week — but is well below the 52-week peak of 100%, meaning there is no meaningful squeeze dynamic in play for now.

Options positioning tells a broadly neutral story. The put/call ratio of 0.90 is fractionally below its 20-day average of 0.91, and the z-score of -0.85 places it comfortably within one standard deviation of normal. After a period in March when calls dominated sharply — the PCR dropped as low as 0.55 — activity has normalised. Neither side of the options market is expressing strong conviction at current levels.

The price action diverges starkly from regional peers. GGAL fell 7.5% over the week while closely correlated Argentine banks BMA and SUPV moved in opposite directions — BMA gained 2.2% and SUPV lost 3.1%. Broader Latin American lenders fared better still: ITUB and NU each added around 2%. GGAL's underperformance looks stock-specific rather than sector-driven, which may partly explain why shorts are building into the event.

The Street remains constructive on paper, but the most recent formal action — a JP Morgan target trim to $72 in February, while maintaining Overweight — implies a meaningful gap between where analysts see fair value and where the stock trades at $42.72. The consensus mean target of $67.43 implies roughly 58% analyst return potential. The PE ratio has compressed to 8.2x, down over 0.35 turns in the past 30 days, while the price-to-book has slipped to 1.09x — both reflecting recent price weakness rather than an earnings-driven re-rating. On the factor side, the EPS surprise score ranks in the 99th percentile, meaning GGAL has a strong track record of beating estimates. Forward EPS growth expectations also rank in the 92nd percentile year-on-year. Near-term EPS momentum is another matter: the 30-day reading ranks in just the 1st percentile, a signal that estimate revisions have stalled or reversed sharply in recent weeks.

Recent earnings history adds a note of caution. The last four events all produced negative next-day moves, ranging from -0.8% to -5.2%. The April 28 result this cycle moved -0.8% on the day. The pattern is not dramatic, but it is consistent: GGAL has not rewarded buyers on results day in recent quarters. Institutional ownership shows a handful of funds adding exposure — T. Rowe Price added roughly 3.8 million shares as of March 31, and Westwood Global initiated a new position — though against a base held overwhelmingly by EBA Holding (24%) and the Argentine Social Security Administration (16.6%), institutional flows at the margin are unlikely to shift the technical picture materially.

The key watch point is the May 22 Q1 earnings release: with short interest building, EPS momentum near a low, and a consistent post-results drift pattern, the setup heading into the print is more defensive than the Street's headline optimism suggests.